"With this (ICON) agreement, we also gain access to a global distribution network for LymPro, including central laboratories in Europe, Singapore, India and China that will allow LymPro to enter these new markets seamlessly through an already established distribution framework."

http://www.thechairmansblog.com/amarantus-bio...vDwRh.dpuf